eighteen evaluable patients with advanced malignant lymphoma were treated with a combination of cis-dichlorodiammineplatinum ( ii ) ( 50 mg/m2 i.v . on day 1 ) , vp 16-213 ( 100 mg/m2 i.v . on days 1 , 3 , 5 ) , and prednisone ( 50 mg/m2 per os on days 1-5 ) , recycling every 2 weeks .
C0024299
malignant lymphoma
C0032952
prednisone